Insider Transactions in Q1 2026 at Ocular Therapeutix, Inc (OCUL)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2026
|
Namrata Saroj Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
79,112
+23.71%
|
-
|
|
Jan 02
2026
|
Peter Kaiser Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
79,112
+22.54%
|
-
|
|
Jan 02
2026
|
Sanjay Nayak Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
64,900
+15.92%
|
-
|
|
Jan 02
2026
|
Steve Lawrence Meyers Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
64,900
+22.97%
|
-
|
|
Jan 02
2026
|
Todd Anderman Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
64,900
+29.86%
|
-
|
|
Jan 02
2026
|
Donald Notman Officer |
BUY
Grant, award, or other acquisition
|
Direct |
79,112
+16.89%
|
-
|
|
Jan 02
2026
|
Jeffrey S. Heier Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
79,112
+19.51%
|
-
|
|
Jan 02
2026
|
Nadia Waheed Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
79,112
+19.51%
|
-
|